Trulieve Cannabis
Market Cap
CA$1.6b
Last Updated
2020/02/18 01:18 UTC
Data Sources
Company Financials +
Executive Summary
Trulieve Cannabis Corp., together with its subsidiaries, operates as a medical marijuana company.
Rewards
Risk Analysis
Snowflake Analysis
Excellent balance sheet and good value.
Share Price & News
How has Trulieve Cannabis's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: TRUL has not had significant price volatility in the past 3 months.
Market Performance
7 Day Return
4.0%
TRUL
5.3%
CA Pharmaceuticals
0.3%
CA Market
1 Year Return
-16.1%
TRUL
-57.6%
CA Pharmaceuticals
5.5%
CA Market
Return vs Industry: TRUL exceeded the Canadian Pharmaceuticals industry which returned -57.9% over the past year.
Return vs Market: TRUL underperformed the Canadian Market which returned 5.8% over the past year.
Shareholder returns
| TRUL | Industry | Market | |
|---|---|---|---|
| 7 Day | 4.0% | 5.3% | 0.3% |
| 30 Day | -0.1% | -14.1% | 0.5% |
| 90 Day | -15.3% | -7.9% | 3.5% |
| 1 Year | -16.1%-16.1% | -57.6%-57.6% | 8.8%5.5% |
| 3 Year | n/a | 12.9%12.1% | 14.8%4.5% |
| 5 Year | n/a | 325.7%325.7% | 34.1%14.5% |
Price Volatility Vs. Market
How volatile is Trulieve Cannabis's share price compared to the market and industry in the last 5 years?
Simply Wall St News
2 months ago | Simply Wall St
Is Trulieve Cannabis Corp. (CNSX:TRUL) A High Quality Stock To Own?4 months ago | Simply Wall St
Some Trulieve Cannabis (CNSX:TRUL) Shareholders Are Down 30%5 months ago | Simply Wall St
What Kind Of Shareholders Own Trulieve Cannabis Corp. (CNSX:TRUL)?Valuation
Is Trulieve Cannabis undervalued compared to its fair value and its price relative to the market?
>50%
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: TRUL (CA$14.14) is trading below our estimate of fair value (CA$54.81)
Significantly Below Fair Value: TRUL is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: TRUL is good value based on its PE Ratio (8.2x) compared to the Pharmaceuticals industry average (16.3x).
PE vs Market: TRUL is good value based on its PE Ratio (8.2x) compared to the Canadian market (15.9x).
Price to Earnings Growth Ratio
PEG Ratio: TRUL is poor value based on its PEG Ratio (3.1x)
Price to Book Ratio
PB vs Industry: TRUL is overvalued based on its PB Ratio (5x) compared to the CA Pharmaceuticals industry average (1.4x).
Next Steps
Future Growth
How is Trulieve Cannabis forecast to perform in the next 1 to 3 years based on estimates from 10 analysts?
2.7%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: TRUL's forecast earnings growth (2.7% per year) is above the savings rate (1.4%).
Earnings vs Market: TRUL's earnings (2.7% per year) are forecast to grow slower than the Canadian market (10.4% per year).
High Growth Earnings: TRUL's earnings are forecast to grow, but not significantly.
Revenue vs Market: TRUL's revenue (22.4% per year) is forecast to grow faster than the Canadian market (5% per year).
High Growth Revenue: TRUL's revenue (22.4% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: TRUL's Return on Equity is forecast to be high in 3 years time (34.5%)
Next Steps
Past Performance
How has Trulieve Cannabis performed over the past 5 years?
339.5%
Last years earnings growth
Earnings and Revenue History
Quality Earnings: TRUL has a high level of non-cash earnings.
Growing Profit Margin: TRUL's current net profit margins (68.5%) are higher than last year (40.7%).
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if TRUL's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Insufficient data to compare TRUL's past year earnings growth to its 5-year average.
Earnings vs Industry: TRUL earnings growth over the past year (339.5%) exceeded the Pharmaceuticals industry -11.3%.
Return on Equity
High ROE: TRUL's Return on Equity (60.5%) is considered outstanding.
Return on Assets
Return on Capital Employed
Next Steps
Financial Health
How is Trulieve Cannabis's financial position?
Financial Position Analysis
Short Term Liabilities: TRUL's short term assets ($242.3M) exceed its short term liabilities ($49.1M).
Long Term Liabilities: TRUL's short term assets ($242.3M) exceed its long term liabilities ($156.3M).
Debt to Equity History and Analysis
Debt Level: TRUL's debt to equity ratio (33.2%) is considered satisfactory.
Reducing Debt: Insufficient data to determine if TRUL's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: TRUL's debt is well covered by operating cash flow (30.6%).
Interest Coverage: TRUL's interest payments on its debt are well covered by EBIT (29.4x coverage).
Balance Sheet
Inventory Level: TRUL has a high level of physical assets or inventory.
Debt Coverage by Assets: TRUL's debt is covered by short term assets (assets are 3.1x debt).
Next Steps
Dividend
What is Trulieve Cannabis's current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Current dividend yield vs market & industry
Notable Dividend: Unable to evaluate TRUL's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.
High Dividend: Unable to evaluate TRUL's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if TRUL's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if TRUL's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of TRUL's dividend in 3 years as they are not forecast to pay a notable one for the Canadian market.
Next Steps
Management
How experienced are the management team and are they aligned to shareholders interests?
0.6yrs
Average management tenure
CEO
Kim Rivers (40yo)
4.7yrs
Tenure
US$150,000
Compensation
Ms. Kimberly Rivers, also known as Kim, serves as Chairman and Chief Executive Officer of Trulieve Cannabis Corp. and has been its Director since November 2015. Ms. Rivers is a member of the Georgia Bar as ...
CEO Compensation Analysis
Compensation vs Market: Kim's total compensation ($USD150.00K) is below average for companies of similar size in the Canadian market ($USD1.58M).
Compensation vs Earnings: Insufficient data to compare Kim's compensation with company performance.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Chairman | 4.7yrs | US$150.00k | 15.06% $234.9m | |
| Chief Financial Officer | 0yrs | US$200.00k | 0.0079% $122.6k | |
| Chief Information Officer | 0yrs | US$150.00k | no data | |
| Director of Investor Relations & Corporate Communications | 0.9yrs | no data | no data | |
| General Counsel & Corporate Secretary | 0.9yrs | no data | no data | |
| Director of Marketing & Community Relations | 0yrs | no data | no data | |
| Chief Sales Officer | 0.3yrs | no data | no data | |
| Chief Marketing Officer | 0.2yrs | no data | no data | |
| Director of Human Resources | 0yrs | no data | 0.0079% $122.6k | |
| Chief Production Officer | 0.3yrs | no data | 0.0079% $122.6k |
0.6yrs
Average Tenure
49yo
Average Age
Experienced Management: TRUL's management team is not considered experienced ( 0.6 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Chairman | 4.7yrs | US$150.00k | 15.06% $234.9m | |
| Director | 0.6yrs | no data | no data | |
| Advisor to the Board | 0.2yrs | no data | no data | |
| Advisor to the Board | 0.2yrs | no data | no data | |
| Independent Director | 4.3yrs | no data | 13.86% $216.3m | |
| Independent Director | 4.3yrs | no data | no data | |
| Independent Director | 4.3yrs | no data | 0.057% $888.0k | |
| Independent Director | 1.7yrs | no data | no data |
1.7yrs
Average Tenure
60.5yo
Average Age
Experienced Board: TRUL's board of directors are not considered experienced ( 1.7 years average tenure), which suggests a new board.
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: TRUL insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Ownership Breakdown
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Company Information
Trulieve Cannabis Corp.'s company bio, employee growth, exchange listings and data sources
Key Information
- Name: Trulieve Cannabis Corp.
- Ticker: TRUL
- Exchange: CNSX
- Founded:
- Industry: Pharmaceuticals
- Sector: Pharmaceuticals & Biotech
- Market Cap: CA$1.560b
- Shares outstanding: 110.35m
- Website: https://www.trulieve.com
Number of Employees
Location
- Trulieve Cannabis Corp.
- 6749 Ben Bostic Road
- Quincy
- Florida
- 32351
- United States
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| TRUL | CNSX (Canadian National Stock Exchange) | Yes | Subordinate Votings Shares | CA | CAD | Sep 2018 |
| TCNN.F | OTCPK (Pink Sheets LLC) | Yes | Subordinate Votings Shares | US | USD | Sep 2018 |
Biography
Trulieve Cannabis Corp., together with its subsidiaries, operates as a medical marijuana company. The company cultivates and produces products in-house and distributes its products to Trulieve branded stores (dispensaries) in Florida, as well as directly to patients through home delivery. It produces approximately 170 stock keeping units, including smokable flowers, flower pods for vaporizing, concentrates, topicals, capsules, tinctures, and vape cartridges. As of January 9, 2020, the company operated through 43 dispensaries in Florida. Trulieve Cannabis Corp. is headquartered in Quincy, Florida.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2020/02/18 01:18 |
| End of Day Share Price | 2020/02/14 00:00 |
| Earnings | 2019/09/30 |
| Annual Earnings | 2018/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.